Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dandelion is more tolerant to cadmium than to nickel excess.
Kováčik J, Bujdoš M, Ketzer P, Babula P, Peterková V, Krenn L. Kováčik J, et al. Among authors: peterkova v. Chemosphere. 2019 Jun;224:884-891. doi: 10.1016/j.chemosphere.2019.02.181. Epub 2019 Feb 27. Chemosphere. 2019. PMID: 30986894
Metal-induced oxidative stress in terrestrial macrolichens.
Kováčik J, Dresler S, Peterková V, Babula P. Kováčik J, et al. Among authors: peterkova v. Chemosphere. 2018 Jul;203:402-409. doi: 10.1016/j.chemosphere.2018.03.112. Epub 2018 Mar 19. Chemosphere. 2018. PMID: 29627607
[Growth hormone - 30 years of clinical practice: past, present, future].
Dedov II, Bezlepkina OB, Pankratova MS, Nagaeva EV, Raykina EN, Peterkova VA. Dedov II, et al. Among authors: peterkova va. Probl Endokrinol (Mosk). 2024 Feb 27;70(1):4-12. doi: 10.14341/probl13432. Probl Endokrinol (Mosk). 2024. PMID: 38433536 Free PMC article. Russian.
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
100 results